Make nextflow pipeline ready to scale in cloud optimization and nf-test integration

Optimizing nextflow pipelines for cloud scalability

Quotient Therapeutics, a company working with deeply sequenced whole-genome sequencing (WGS) data, faced growing computational demands. As the number of processed samples increased, they needed to optimize their Nextflow-based pipelines for better efficiency, reliability, and cost-effectiveness.

Challenge

The client’s pipeline was struggling to keep up with increasing workloads, resulting in longer processing times and rising compute costs. Ensuring consistent reliability was also a key priority to maintain high-quality data outputs.

Approach

A multi-tiered optimization strategy was implemented:

  • Comprehensive review of pipeline code, tools, and environments to identify optimization opportunities.
  • Integration of nf-test for automated validation and CI/CD workflows.
  • Optimization across three levels: bioinformatics, software engineering, and cloud DevOps.

Results

  • Reliability improved through automated integration tests before every deployment.
  • Processing cost reduced by 64%.
  • Execution time reduced by 63%, enabling sample processing within the target 24-hour window

Through strategic optimization of bioinformatics pipelines in an AWS Batch environment, Quotient Therapeutics achieved significant cost savings and efficiency gains. The improvements ensured the scalability and reliability of their workflow, preparing them for continued growth.

Discover more: Our FOG 2025 presentation on this project

For a deeper dive into this project and similar successful case studies, watch our presentation.

or more insights from this key event, explore our highlights from the Festival of Genomics & Biodata

Our team recently presented on these advancements at the Nextflow Summit 2024, showcasing how we enhance open science in Big Pharma.

Want to achieve similar efficiency gains? Let's discuss how we can optimize your bioinformatics workflows.

You might be also interested in:

Your monthly AI in biotech digest – August
Nature Methods cover image and cell morphology visualization from JUMP Cell Painting study
New publication in Nature Methods: How gene activity shapes cell structure
Scientist working in a laboratory environment, symbolizing biotech innovation and AI-driven drug discovery.
New publication: Biologically relevant models and AI increase scalability in CRC drug screening
Scientist analyzing high-content cell images on a computer screen – visualizing AI-driven phenotypic profiling in drug discovery.
The Future of Drug Discovery: Integrating Phenotypic Data with Omics and AI

Contact

Ready to transform drug discovery?

Discover how one of the top AI CROs in the world, can be your trusted partner in revolutionizing drug discovery through AI.

Contact us today to learn more about our tailored solutions for empowering your drug development journey.

Send us a message and we will contact you back within 48 hours.

Newsletter

Become an insider

Be the first to know about Ardigen’s latest news and get access to our publications, webinars and more!